ALLPCB
Market demand driving sustained output growth
Economic development, improvements in health insurance, reforms of the medical service system, and rising public healthcare demand will drive continued growth in medical device consumption. With the deepening of medical reform policies and the pilot implementation of hierarchical diagnosis and treatment, rural and township health institutions are likely to become markets with large potential. Population aging and higher living standards will promote rapid growth in in vitro diagnostics, orthopedics, and rehabilitation device sectors. Under the stimulus of market demand and a background of stable economic growth, China’s medical device industry is expected to remain in a rapid development phase.
Technological innovation supporting healthy industry growth
To promote industrial innovation, China has implemented a series of science and technology funding programs that provide platforms and a foundation for medical device technology development. A market-oriented innovation system centered on enterprises and integrating industry, academia, research, and clinical use is gradually taking shape.
Major product breakthroughs have been achieved in China’s medical device field, with concentrated innovative outcomes and a number of important advances described as independently original or moving from nothing to existence and from low to high capability. A range of digital, intelligent, and portable medical devices have been adopted in primary care institutions. The endogenous momentum and vitality for independent innovation in China’s medical device sector have significantly increased, supporting further localization of medical devices.
Key raw materials for high-end medical consumables still rely on imports
High-end medical consumables combine precision mechanical technology, laser technology, radiation and nuclear techniques, magnetic technology, sensing technology, chemical detection, and biomedical technologies. The competitive core lies in one or more cutting-edge core processes that incorporate these technologies. China has become a major global manufacturing base but is not yet a manufacturing leader; the import ratio for core raw materials in high-end medical consumables remains high, and the capability to develop complementary products is insufficient.
Domestic firms lag behind Western manufacturers in high-end equipment
Domestic medical device firms are still dominated by lower-technology disposable products and small to medium-sized devices. After nearly 30 years of development, Chinese companies can produce the majority of commonly used medical devices. The number of manufacturers in China with a certain production scale already exceeds the combined total of many European and US firms, and China has the largest global production capacity in disposable medical devices and low-end equipment. However, large foreign manufacturers possess advanced technology, substantial capital, and concentrated talent. They have extensive experience in R&D of large high-end devices and hold core technologies for major high-end products. By leveraging financial and brand advantages through acquisitions or OEM arrangements, they can enter basic medical device markets and apply downward pressure on costs, posing strong competitive challenges to Chinese manufacturers. In the high-end equipment market, domestic firms still trail their European and US counterparts.
Weak industrial manufacturing base
As the division of labor becomes more detailed and market transactions increase, the medical device industry chain has extended while becoming more complete and optimized. Upstream industries exert significant constraints on medical device development, especially machinery, materials, and electronics, which directly influence technological directions. Compared with developed countries, China’s manufacturing industrial base is relatively weak, and this has become an important constraint on leapfrog development of the medical device industry.
Shortage of high-end R&D and manufacturing talent
Medical devices are multidisciplinary, high-tech products involving mechanical engineering, optics, electronics, information, and materials science. Product validation also involves biological evaluation, animal testing, clinical trials, experimental design, and statistical analysis. High-end innovation requires personnel with multidisciplinary knowledge. Currently, talent in China’s medical device sector is concentrated in sales, maintenance, and regulatory registration. Compared with developed countries, China has gaps in both the quantity and quality of R&D personnel and precision instrument manufacturing staff. Shortages of device design and structural engineers, biomedical electronics engineers, and polymer R&D specialists directly limit the industry's ability to improve international competitiveness.
Restrictions from foreign non-tariff barriers
Governments impose strict market access regulations and management for medical devices, such as FDA registration in the United States and CE certification in the European Union. China still lags behind developed countries in production process management and quality assurance systems, and relatively few Chinese manufacturers and products have obtained international certifications. Exports of Chinese medical devices face a range of non-tariff trade barriers, including certification and environmental standards. Domestic medical device firms also lack sufficient professional talent with international market operation experience and have limited international trade experience, making it difficult to enter overseas markets.
